DOTATATE Uptake in an Axillary Lymph Node After COVID-19 Vaccination

James Brophy, Gregory Henkle, Eric M. Rohren

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

A 58-year-old man underwent DOTATATE PET/CT scan for follow-up of pulmonary neuroendocrine tumor after resection and adjuvant chemotherapy. On screening paperwork, the patient indicated having received the Johnson & Johnson/Janssen COVID-19 vaccine (Janssen Biotech, Inc) 1 day previously, administered in the right deltoid muscle. Reactive changes in regional lymph nodes is a known response for all 3 currently Food and Drug Administration-approved COVID-19 vaccines. Recent published data have demonstrated FDG PET-avid axillary lymphadenopathy subsequent to COVID-19 vaccination, and included here is a report of DOTATATE PET-avid axillary lymph node after injection of the Johnson & Johnson COVID-19 vaccine.

Original languageEnglish (US)
Pages (from-to)174-175
Number of pages2
JournalClinical Nuclear Medicine
Volume47
Issue number2
DOIs
StatePublished - Feb 1 2022

Keywords

  • COVID-19
  • DOTATATE
  • PET
  • lymphadenopathy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'DOTATATE Uptake in an Axillary Lymph Node After COVID-19 Vaccination'. Together they form a unique fingerprint.

Cite this